JamesFrankListMD

Diabetes, Lipid Metabolism

Physician

Dr. List is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2003
Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 1996 - 2000
University of Minnesota Medical SchoolClass of 1996

PubMed

17 citations
New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.
Hiddo J.L. Heerspink, James List, Vlado Perkovic
Diabetes, Obesity & Metabolism. 2018-10-07
162 citations
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
W. Timothy Garvey, Luc Van Gaal, Lawrence A. Leiter, Ujjwala Vijapurkar, James List
Metabolism. 2018-08-01
65 citations
Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes.
C. David Sjöström, Peter A. Johansson, Agata Ptaszynska, James F. List, Eva Johnsson
Diabetes & Vascular Disease Research. 2015-05-25

Journal Articles

New Clinical Trial Designs for Establishing Drug Efficacy and Safety in a Precision Medicine Era
James List, MD, Diabetes, Obesity and Metabolism

Late-Breaking Phase 3 a DUE Data Show Investigational Single-Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Haemodynamics Versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)March 6th, 2023
Janssen Announces Late-Breaking Data from Two Gene Therapy Programs at the American Academy of Ophthalmology 2022 Annual MeetingOctober 1st, 2022
Johnson & Johnson : The Janssen Pharmaceutical - New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO (Rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related EventsSeptember 30th, 2021
Join now to see all